Patent: 6,558,695
✉ Email this page to a colleague
Summary for Patent: 6,558,695
Title: | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
Abstract: | A method is provided for increasing the permeability of skin or mucosal tissue to a topically or transdermally administered pharmacologically or cosmeceutically active peptide, polypeptide or protein. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the peptide, polypeptide or protein through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery devices employing hydroxide-releasing agents as permeation enhancers are provided as well. |
Inventor(s): | Luo; Eric C. (Plano, TX), Hsu; Tsung-Min (San Diego, CA) |
Assignee: | Dermatrends, Inc. (San Diego, CA) |
Application Number: | 09/737,831 |
Patent Claims: | see list of patent claims |
Details for Patent 6,558,695
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2019-12-16 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2019-12-16 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2019-12-16 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |